ArticleFrontiers in pharmacology2026
Evaluation of tilapia skin (
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Skin wounds are common in horses due to species-specific behavioral responses. Equine skin morphology, vascularization, and inflammatory responses to wounds are comparable to those in humans, supporting the translational relevance of equine wound-healing studies. Investigating biomaterials such as tilapia and frog skin may improve wound management. This study demonstrated that sterilized tilapia and frog skin exhibit promising wound-healing properties. Materials and Methods: Macroscopic, microscopic, and thermographic aspects of second-intention wound healing were compared in six horses with surgically induced skin wounds treated topically with frozen tilapia skin (FTS), sterilized tilapia skin (STS), sterilized frog skin (SFS), or lactated Ringer's solution (CW). Wounds were created bilaterally in the thoracolumbar region, with one side designated for histopathological evaluation and the contralateral side for macroscopic assessment, including photographic documentation, wound area measurement, contraction rate, and thermographic analysis. Treatments were applied daily, and wound progression was monitored for 28 days. Evaluations were performed on days 0, 3, 7, 14, 21, and 28 after wound induction. Results: No clinical abnormalities were observed in the horses throughout the study. Regarding wound area, the FTS group exhibited the largest lesions on day 14 compared with the CW group. Over time, the CW and FTS groups showed reduced wound contraction, with increased wound area on day 7. Histopathological evaluation revealed a significant increase in polymorphonuclear cells (PMNs) in all groups on day 3, which persisted until day 7 in the CW group and until day 28 in the FTS group. Thermographic analysis showed no significant differences among treatments. Conclusion: Sterilized tilapia skin reduced the inflammatory response, enhanced wound-edge contraction, and accelerated healing. Frog skin was associated with faster reduction of edema and hemorrhage, as well as more pronounced fibroplasia during the early stages of healing. In contrast, frozen tilapia skin showed limitations, including lower adherence to the wound bed, increased contamination, and delayed healing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.